'Pfizer Ltd delivered tremendous growth of 45% in revenue YOY along with terrific growth in EBITDA & PAT of 46% & 61% YOY with better operational efficiency & decline in employee benefit expenses leading to better Net profit margins overall'
You like to know more. We like that!
Please subscribe Model Portfolio Plan to get access of all premium model portfolio articles Only at Rs 7499/Year.
Please login to view this free article.
This blog is available only for logged in users, please register and get access to view this article.